- Home
- BANL vs LSTA Comparison
BANL vs LSTA Comparison
Compare BANL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- LSTA
- Stock Information
- Founded
- BANL 2015
- LSTA 1980
- Country
- BANL Malaysia
- LSTA United States
- Employees
- BANL N/A
- LSTA N/A
- Industry
- BANL Oil Refining/Marketing
- LSTA Misc Health and Biotechnology Services
- Sector
- BANL Energy
- LSTA Health Care
- Exchange
- BANL Nasdaq
- LSTA Nasdaq
- Market Cap
- BANL 22.8M
- LSTA 24.2M
- IPO Year
- BANL 2023
- LSTA N/A
- Fundamental
- Price
- BANL $0.89
- LSTA $2.67
- Analyst Decision
- BANL
- LSTA Strong Buy
- Analyst Count
- BANL 0
- LSTA 1
- Target Price
- BANL N/A
- LSTA $15.00
- AVG Volume (30 Days)
- BANL 9.1K
- LSTA 18.6K
- Earning Date
- BANL 09-12-2024
- LSTA 11-12-2024
- Dividend Yield
- BANL N/A
- LSTA N/A
- EPS Growth
- BANL N/A
- LSTA N/A
- EPS
- BANL N/A
- LSTA N/A
- Revenue
- BANL $521,173,543.00
- LSTA N/A
- Revenue This Year
- BANL N/A
- LSTA N/A
- Revenue Next Year
- BANL N/A
- LSTA N/A
- P/E Ratio
- BANL N/A
- LSTA N/A
- Revenue Growth
- BANL 24.34
- LSTA N/A
- 52 Week Low
- BANL $0.55
- LSTA $2.19
- 52 Week High
- BANL $1.79
- LSTA $3.83
- Technical
- Relative Strength Index (RSI)
- BANL 44.04
- LSTA 42.40
- Support Level
- BANL $0.77
- LSTA $2.52
- Resistance Level
- BANL $0.91
- LSTA $2.75
- Average True Range (ATR)
- BANL 0.05
- LSTA 0.19
- MACD
- BANL -0.00
- LSTA -0.01
- Stochastic Oscillator
- BANL 54.55
- LSTA 56.52
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.